During spinal cord development, astrocyte precursors arise from neuroepithelial progenitors, delaminate from the ventricular zone, and migrate toward their final locations where they differentiate. Although the mechanisms underlying their early specification and late differentiation are being deciphered, less is known about the temporal control of their migration. Here, we show that the epithelialmesenchymal transition regulator Zeb1 is expressed in glial precursors and report that loss of Zeb1 function specifically delays the onset of astrocyte precursor delamination from the ventricular zone, correlating with transient deregulation of the adhesion protein Cadherin-1. Consequently, astrocyte precursor invasion into the Zeb1 À/À mutant white matter is delayed, and induction of their differentiation is postponed. These findings illustrate how fine regulation of adhesive properties influences the onset of neural precursor migration and further support the notion that duration of exposure of migrating astrocyte precursors to environmental cues and/or their correct positioning influence the timing of their differentiation.
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In Brief Ohayon et al. show that the EMT regulator Zeb1 is expressed in embryonic glial precursors and report that loss of Zeb1 function specifically delays the onset of spinal cord astrocyte precursor emigration from the ventricular zone, an early defect that is later associated with postponed induction of their differentiation.
SUMMARY
During spinal cord development, astrocyte precursors arise from neuroepithelial progenitors, delaminate from the ventricular zone, and migrate toward their final locations where they differentiate. Although the mechanisms underlying their early specification and late differentiation are being deciphered, less is known about the temporal control of their migration. Here, we show that the epithelialmesenchymal transition regulator Zeb1 is expressed in glial precursors and report that loss of Zeb1 function specifically delays the onset of astrocyte precursor delamination from the ventricular zone, correlating with transient deregulation of the adhesion protein Cadherin-1. Consequently, astrocyte precursor invasion into the Zeb1 À/À mutant white matter is delayed, and induction of their differentiation is postponed. These findings illustrate how fine regulation of adhesive properties influences the onset of neural precursor migration and further support the notion that duration of exposure of migrating astrocyte precursors to environmental cues and/or their correct positioning influence the timing of their differentiation.
INTRODUCTION
Oligodendrocytes and astrocytes constitute the main glial cell populations of neural origin within the CNS. During embryogenesis, glial precursors arise from neural stem cells located in the ventricular zone (VZ), after a primary phase of neurogenesis, delaminate and migrate toward their final locations where they differentiate. In the developing spinal cord, oligodendrocyte precursors (OPs) are generated from specific progenitor domains along the dorsoventral (DV) axis, while astrocyte precursors (APs) are produced from all progenitor domains in a ventral-todorsal temporal sequence (Rowitch and Kriegstein, 2010; Tripathi et al., 2011; Tien et al., 2012) . The molecular mechanisms controlling the gliogenic switch are beginning to be deciphered and involve the Sox9 transcription factor that acts upstream of NFIa to coordinate the arrest of neurogenesis and initiation of gliogenesis (Stolt et al., 2003; Deneen et al., 2006; Kang et al., 2012) . Also, extensive studies have identified several key signaling pathways and transcriptional regulators controlling OP and AP differentiation (Kessaris et al., 2008; Rowitch and Kriegstein, 2010; Emery and Lu, 2015) .
In contrast, relatively less is known about the time window during which newly specified OPs and APs have to exit the VZ and invade the mantle zone (MZ). Zeb1 and Zeb2 form a small family of transcription factors involved in many developmental and physiopathological processes, including epithelial-mesenchymal transitions (EMTs) and the formation of neural crestderived tissues (Van de Putte et al., 2003; Gheldof et al., 2012; Rogers et al., 2013; Ohayon et al., 2015) . Recent findings have established that Zeb2 controls OP maturation around birth (Weng et al., 2012) . Here we show that Zeb1 is expressed in embryonic glial precursors and report its implication in the temporal control of AP migration.
RESULTS AND DISCUSSION

Zeb1 and Zeb2 Exhibit Dynamic Expression Profiles in the Mouse Developing Spinal Cord
During the neurogenic phase of the developing spinal cord, between embryonic days (E)9.5 and 12.5, we observed increasing levels of Zeb1 in VZ progenitors ( Figures 1A, 1B , and 1J) that also expressed Zeb2 at these stages (Figures S1A-S1C and 1J). In the MZ, whereas Zeb2 was maintained in discrete neuronal populations (Figures S1C-S1E and 1J), Zeb1 was gradually downregulated in post-mitotic neurons, except in motoneurons (MNs; Figures 1B, 1C, 1F , and 1J). During the gliogenic phase, Zeb1 was maintained in VZ progenitors ( Figures 1C-1E and 1J ), while Zeb2 was downregulated from E12.5 and became undetectable in these cells by E13.5 ( Figures S1C, S1D , and 1J). At E13.5, Zeb1-positive (+) cells were observed in the ventral MZ ( Figures  1C and S1J) , and their number increased subsequently with a spatial distribution reminiscent of glial precursors ( Figures 1D,  1E , and S1K). At E18.5, we confirmed that Zeb1 was largely excluded from NeuN+ neuronal populations except in MNs (Figure 1F ), but it was detected in Olig2+ OPs ( Figures 1E, 1G , and 1J) and GFAP+ APs ( Figures 1E, 1H , 1I, and 1J). In contrast, Zeb2 was excluded from migrating OPs and APs at early stages, but it was selectively induced in OPs from E16.5 (Figures S1F, S1G, and 1J; Weng et al., 2012) .
At adulthood, Zeb1 was maintained in a small fraction of Sox10+ and Olig2+ cells (Figures 1K and 1L) that were negative for the mature oligodendrocyte marker CC1 ( Figure 1M ), indicating that they were adult OPs. Moreover, co-expression of Zeb1 with AldoC and GFAP ( Figures 1N and 1O) showed that mature astrocytes maintained Zeb1. A similar pattern of Zeb1 was observed in the adult cortex ( Figures S1L and S1M ). Altogether, these data show the following: (1) during neurogenesis, spinal cord VZ progenitors express both Zeb2 and Zeb1, albeit at low levels, while only Zeb1 is robustly expressed in these cells during gliogenesis; (2) Zeb1 is maintained in migrating OPs and APs throughout embryogenesis; and (3) Zeb1 constitutes a specific marker for adult OPs and mature astrocytes.
Spinal Cord APs Are Selectively Affected in Zeb1
À/À Mutants These observations prompted us to assess glial cell formation in Zeb1 À/À animals (Takagi et al., 1998 ; see Figures S1N-S1Q) by mainly focusing on the spinal cord. First, analysis of the spatiotemporal expression profile of OP determinants, including Olig2, Sox10, PDGFra, and PLP1 between E12.5 and E18.5, showed that Zeb1 is dispensable for the earliest phases of OP formation ( Figures S2A-S2Q ). In contrast, time course analysis of Fgfr3 expression (Pringle et al., 2003) revealed a specific requirement for Zeb1 in APs. Indeed, in wild-type (WT) embryos, migrating Fgfr3+ APs in the MZ normally emerged in a ventral-todorsal sequence starting at E13.5, and they expanded to populate the entire width of the spinal cord by E18.5 (Figures 2A, 2C , 2E, 2G, 2I, and 2K; Tien et al., 2012) . Strikingly, at E13.5, virtually no Fgfr3+ AP was detected in the MZ of Zeb1 À/À embryos (Figure 2B ). At E14.5, a few migrating APs were visualized, though at locations and in numbers reminiscent of WT at E13.5 (Figures 2A,  2D , 2M, and 2N). Also at E15.5, E16.5, and E17.5, the pattern of Fgfr3+ cells in the mutant MZ resembled that of WT at E14.5, E15.5, and E16.5, respectively ( Figures 2C-2J ). Consistent with that, quantification revealed a deficit of APs in the MZ of Zeb1 À/À embryos until E17.5 ( Figures 2M and 2N ).
However, from E14.5, numbers of APs in the mutant MZ progressively increased similarly to WT, albeit with a 24-hr delay, and eventually they reached a close to normal complement by E18.5 ( Figures 2K-2N ). BrdU incorporation experiments performed at E16.5 revealed that the proportion of migrating Fgfr3+ APs that were also BrdU+ was comparable in both genotypes (11.31% ± 2.38% in WT versus 10.38% ± 2.42% in Zeb1 À/À mutants; Figures To characterize this defect, we first assessed cell proliferation in the VZ at E13.5 by determining the proportion of Ki67+ cycling progenitors that have incorporated BrdU during a 2-hr pulse. In WT, divergences were observed along the DV axis (21.9% ± 2.45% dorsally versus 40.5% ± 4.9% ventrally), and no significant differences were found in the mutants (22.6% ± 2.56% dorsally versus 41.8% ± 4.6% ventrally; Figures 2X ). This further illustrated that, while migrating OPs were detected on time in the mutants, APs were specifically affected. Second, we established that loss of Sox9 function did not affect Zeb1 expression, thus revealing no epistatic relationships between the two factors (Figures S1R and S1S). Third, we analyzed Aldh1l1, whose onset of expression in the VZ is a good landmark of AP specification. Indeed, Aldh1l1 was induced at E12.5 in the ventralmost domain of the VZ from which the first migrating APs arise 1 day later, and it expanded dorsally at E13.5 (Figures 2Y and 2AA; Tien et al., 2012) . Analysis of Zeb1 À/À mutants revealed that, although at E13.5 virtually no Aldh1l1+ AP was detected in the MZ, the spatiotemporal profile of Aldh1l1 in the VZ appeared normal (Figures 2Z and 2AB) , supporting the view that loss of Zeb1 function does not perturb the timing of AP specification. In line with this, analysis of spinal cord neuronal populations did not reveal any significant changes in Zeb1 À/À animals ( Figures S3A and S3B) , (Stolt et al., 2003) , indicating that Zeb1 is dispensable for the gliogenic switch. We also excluded a role for Zeb1 in early survival of APs ( Figure S3C ). We finally determined that loss of Zeb1 function did not affect the expression of patterning genes, including Nkx2-2, Nkx6-1, or Pax6 ( Figure S3D ). Consistent with that, positional identity of APs that exhibit complementary expression of Slit1 and Reelin according to their origin along the DV axis (Hochstim et al., 2008) was preserved in the mutants, albeit with a 24-hr delay ( Figure S3E ). Altogether, these data show that AP specification, proliferation, survival, and positional identity appear normal in Zeb1 À/À embryos, suggesting that delayed AP invasion into the mutant MZ rather reflected impaired migration. To assess AP migration, we took advantage of the singular expression profile of the extracellular matrix glycoprotein TnC (Karus et al., 2011) . Indeed, in WT embryos, TnC was not detected in the VZ at E12.5 ( Figure S4A ), but it was homogenously induced at E13.5 except in the most ventral VZ domain, which only exhibited scattered expression ( Figures 3A and S4B) . Nevertheless, APs migrated out of this domain and TnC+ APs were detected in the MZ adjacent to it ( Figures 3A, S4B , and S4C), showing that at ventral positions TnC is mainly induced once APs have initiated their migration. In Zeb1 À/À embryos, TnC was normally induced at E13.5, but, whereas no TnC+ AP was found in the MZ at this stage, many TnC+ cells were concomitantly observed in the ventral VZ domain abutting the floor plate ( Figure 3B ), a phenotype still evident at E14.5 and E15.5 ( Figures 3C-3G ). In addition, at E16.5, but not E17.5, clusters of TnC+ cells were still abnormally detected in the dorsal VZ domain of Zeb1 À/À embryos ( Figures 3H-3K ). These data show that, in Zeb1 À/À mutants, newly specified APs remain transiently blocked in the VZ and start to migrate with a 24-hr delay.
Relatively little is known about the molecular determinants controlling the onset of AP migration, although roles for TnC itself (Karus et al., 2011) and Apcdd1 (Kang et al., 2012) have been proposed. However, analyses of both markers in Zeb1 À/À embryos did not reveal any alteration of their expression ( Figures 3A, 3B , S4D, and S4E), suggesting alternative mechanisms. Zeb1 is a major regulator of EMT, notably acting through direct repression of the gene encoding the adhesion molecule Cadherin-1 (Cdh1; Gheldof et al., 2012) . Chromatin immunoprecipitation (ChIP) assays performed on E13.5 spinal cords revealed that Zeb1 actually binds proximal regions of the Cdh1 promoter in vivo (Figure 3L ), prompting us to assess its expression in the mutants. In contrast to WT spinal cords in which Cdh1 expression was under detectable thresholds at all stages analyzed, in Zeb1 À/À embryos Cdh1 was ectopically detected in the VZ, first ventrally at E12.5, then in more dorsal regions until E16.5 ( Figure 3M ). This result is strikingly reminiscent of the deregulation of Cdh1 previously described in several brain regions of Zeb1 À/À mutants at late embryonic stages (Liu et al., 2008) . In many tissues and cancer cells, the presence of Cdh1 is incompatible with a migratory phenotype (Gheldof and Berx, 2013) . In line with this, ex ovo electroporation of E6 chick spinal cords that were cultured as explants for 48 hr showed that Cdh1-transfected cells had a significantly higher tendency to remain in the VZ compared to cells transfected with a control vector ( Figures 3N-3P ). Thus, transient derepression of Cdh1 may provide one mechanism by which the onset of AP emigration is impaired in Zeb1 À/À mutants.
It is of note that levels of ectopic Cdh1 were lower compared to its endogenous expression sites (insets in Figure 3M ) and that no Cdh1+ cells were observed in the MZ when mutant APs eventually delaminated ( Figure 3M ), suggesting that other determinants act in parallel to Zeb1 to finally repress Cdh1. Interestingly, these findings illustrate some similarities between the processes of AP delamination from the VZ and EMT, and they are highly reminiscent of the impaired migration of neural crest cells consequent to Zeb2 knockdown, reflecting deregulation of Cdh1 in the dorsal neural tube at early stages ( Van de Putte et al., 2003; Rogers et al., 2013) . They are also strikingly evocative of the function of Scratch1/2 transcription factors in controlling the onset of cortical neuron precursor migration through repression of Cdh1 (Itoh et al., 2013) . To a lesser extent, they recall the role of Foxp2/4 proteins in repressing Cdh2 in young spinal cord neurons, thus allowing their detachment from the VZ (Rousso et al., 2012 ), though we did not observe obvious alteration of Cdh2 expression in Zeb1 À/À mutants (Figures S4F and S4G) . Altogether, these data show that fine regulation of cell-adhesive properties appears as a widespread process involving multiple families of transcriptional regulators at distinct stages and locations throughout the developing nervous system, which influences neural precursor migration. Intriguingly, in contrast to APs, OP migration occurred on time in Zeb1 À/À mutants. This may reflect that OPs start to migrate earlier than APs, at around E12.5 (Figures S2R and S2S ; Touahri et al., 2012) . At that time, there was no deregulation of Cdh1 in the mutant Olig2+ domain ( Figures S2T and S2U ), and Zeb2 expression was still ongoing in the VZ, albeit at low levels (Figure S1C ). In the same line, no obvious defect was observed during the earlier neurogenic phase in Zeb1 À/À embryos. During this period, Zeb2 was expressed in the VZ and Zeb1 was only detected at low levels (Figures 1A and S1A-S1C). Thus, although roles for Zeb1 during neurogenesis and oligodendrogenesis cannot be totally ruled out, the dynamic spatiotemporal profile and levels of Zeb proteins combined with possible functional redundancies may account for the apparent specific requirement of Zeb1 in APs.
Early Defects of AP Migration or Specification Later Perturb Their Differentiation
At spinal levels, induction of the GFAP protein is a classic indicator of the differentiation of AP subtypes, starting at around E16.5 when cells have reached the pial surface of the spinal cord (Rowitch and Kriegstein, 2010; Hong and Song, 2014) . At this stage, analysis of Zeb1 À/À embryos revealed that fewer APs had settled Arrowhead in (AA) points toward migrating APs in the ventral MZ. Scale bars, 100 mm. In (M), (N), (P), and (R), data are represented as mean ± SEM (**p < 0.01 and ***p < 0.001). See also Figures S1-S3 .
at the margin of the spinal cord compared to WT ( Figures 4A and  4B) , consistent with the fact that they leave the VZ in a delayed manner. Strikingly, in parallel we found that GFAP expression was reduced in the mutant white matter compared to WT and was not concomitantly ectopically detected in the gray matter ( Figures 4D and 4E ). This suggested that early delay of AP migration later perturbs the timing of their differentiation. To further test this issue, we analyzed Sox9 D/D mutants in which glial cell specification and, in turn, migration were delayed by 24 hr. In agreement with previous findings (Stolt et al., 2003) , we observed that at E16.5 fewer APs had invaded the mutant white matter ( Figure 4C ), and we found that GFAP expression also was reduced at this stage ( Figure 4F ), thus echoing the Zeb1 À/À mutant phenotype. By E18.5, however, robust expression of GFAP was observed ventrally in Zeb1 À/À embryos (arrowheads in Figures 4G and 4H ), which correlated with the presence of numerous Fgfr3+/Slit1+ APs in the ventral white matter (arrowheads in Figures 4I-4L ). At more dorsal positions, however, levels of GFAP were still slightly reduced compared to WT (brackets in Figures 4G and 4H) , correlating with fewer Fgfr3+/ Reelin+ cells located at the margin of the mutant spinal cord compared to WT (brackets in Figures 4I, 4J, 4M, and 4N ). These results thus show that early defects of AP migration or specification, respectively, in Zeb1 À/À and Sox9 D/D mutants are later associated with delayed invasion of the white matter by APs and postponed induction of GFAP. These data further support the notion that duration of AP exposure to environmental cues and/or their correct positioning influence the timing of their differentiation (Barnabé -Heider et al., 2005; Hong and Song, 2014) . It is of note that the embryonic lethality of Zeb1-deficient mice precluded full assessment of glial cell differentiation that largely proceeds at post-natal stages. Moreover, the fact that at adulthood Zeb1 is specifically maintained in mature astrocytes and adult OPs, which both retain some precursor-like properties and migratory capacities, leaves open the possibility that this transcriptional regulator also may influence adult gliogenesis. Conditional knockdown approaches will certainly help to address these issues. tained and genotyped as previously described (Takagi et al., 1998; Stolt et al., 2003) .
Astrocyte Culture
Astrocytes were prepared from E18 WT embryos as previously described (Perraud et al., 1990 ).
Histological Analyses
Simple or double in situ hybridization and immunofluorescent staining on cryosections were performed as previously described (Venté o et al., 2012) . Antisense RNA probes for Aldh1L1, Apcdd1, Chx10, Fgfr3, Gata3, Lbx1, Pax6, PdgfRa, PLP1, Reelin, Sim1, Slit1, Shh, Sox10, Tlx3 , and TnC were used. Antibodies used in this study were as follows: goat AldoC (Santa Cruz Biotechnology), mouse APC (clone CC1; Calbiochem), rat BrdU (Abcam), rat Cadherin-1 (Alexis Biochemicals), rabbit Cadherin-2 (Abcam), rabbit and mouse GFAP (Dako), rabbit Ki67 (Abcam), mouse NeuN (Millipore), rabbit NFIa (Active Motif), goat Olig2 (Santa Cruz Biotechnology), goat Sox2 (Abcam), rabbit Sox9 (Stolt et al., 2003) , guinea pig Sox10 (gift of M. Wegner), rabbit Zeb1 (Darling et al., 2003) , and rabbit Zeb2 (Santa Cruz Biotechnology). Alexa Fluor 594-, 488-, or 647-conjugated secondary antibodies (Thermo Fisher Scientific) were used. Apoptosis was assessed using the ApopTag peroxidase detection kit (Millipore). For proliferation assays, BrdU (Sigma) was injected intraperitoneally into pregnant mice (2 mg/animal) at E13.5 or E16.5, 2 hr before sacrifice. For BrdU detection, slides were incubated in 10 mM sodium citrate buffer (pH 6.0) at 95 C for 15 min, then at room temperature (RT) for 15 min, and subjected to immunostaining. For double Fgfr3/BrdU experiments, Fgfr3 in situ hybridization was performed first.
ChIP
ChIP assay was performed as previously described (Nè 
Chick Electroporation
This was performed as previously described (Touahri et al., 2012 ) using a pcDNA3-Cdh1 expression vector (gift of P. Cossart) or a truncated form of the same vector (pcDNA3-DCdh1).
Cell Counts
Quantification in mice was carried out on three independent embryos of each genotype. For chick experiments, two independent experiments were performed and sections from four explants for each condition were analyzed. Cell counts were performed using the ImageJ software.
Statistical Analyses
Quantitative analyses were statistically analyzed using Student's t test and represented as mean ± SEM. 
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